Core Laboratories NV
NYSE:CLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (15.7), the stock would be worth $18.36 (10% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 14.3 | $16.64 |
0%
|
| 3-Year Average | 15.7 | $18.36 |
+10%
|
| 5-Year Average | 21 | $24.55 |
+48%
|
| Industry Average | 13.1 | $15.28 |
-8%
|
| Country Average | 15.6 | $18.23 |
+10%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$853.1m
|
/ |
Jan 2026
$59.4m
|
= |
|
|
$853.1m
|
/ |
Dec 2026
$58.9m
|
= |
|
|
$853.1m
|
/ |
Dec 2027
$66.7m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
|
Core Laboratories NV
NYSE:CLB
|
767m USD | 14.3 | 25.9 | |
| US |
|
Schlumberger NV
NYSE:SLB
|
78.9B USD | 15.1 | 23.4 | |
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
59.5B USD | 16.7 | 23 | |
| US |
|
Halliburton Co
NYSE:HAL
|
31.9B USD | 11.9 | 24.8 | |
| LU |
|
Tenaris SA
MIL:TEN
|
25.7B EUR | 12.2 | 16 | |
| UK |
|
TechnipFMC PLC
NYSE:FTI
|
29B USD | 20.2 | 30.1 | |
| CN |
|
Yantai Jereh Oilfield Services Group Co Ltd
SZSE:002353
|
120.8B CNY | 33.3 | 43.1 | |
| UK |
|
Subsea 7 SA
OSE:SUBC
|
86.8B NOK | 11.5 | 22.3 | |
| IT |
|
Saipem SpA
MIL:SPM
|
7.6B EUR | 10 | 24.8 | |
| FR |
|
Technip Energies NV
PAR:TE
|
6.9B EUR | 10.8 | 19 | |
| CN |
|
Sinopec Oilfield Service Corp
SSE:600871
|
51B CNY | 39.6 | 77.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 12.2 |
| Median | 15.6 |
| 70th Percentile | 20.9 |
| Max | 706 |
Other Multiples
Core Laboratories NV
Glance View
Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. The company is headquartered in Amstelveen, Noord-Holland and currently employs 3,700 full-time employees. The firm operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The company provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
